BioSpace News Archive

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.

EmblemHealth, one of the nation’s largest non-profit health insurers, announced that effective January 1, 2020, it has significantly reduced the number of medical procedures for which members will require prior authorization before receiving care.

In accordance with the merger agreement, Illumina will pay Pacific Biosciences a termination fee of $98 million.

The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.

Company to hold conference call Friday, January 3, 2020 at 8:30 am Eastern Time

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive Vice President and COO; and Ilan Daskal, Executive Vice President and CFO will participate in the 38th Annual J.P. Morgan Healthcare Conference